Raadi | Blue Cross MN

Soo bandhiga 2491 - 2500 ee natiijooyinka 3563

Bixiye

P32-19 eviCore Radiology Program Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management Program

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

P34-19 Change to Prior Authorization Requirements for Outpatient Therapies and Chiropractic Services for Commercial and Medicare Products

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

P26R1-19 Update: New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business – Effective May 6, 2019

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

P36-19 Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Utilization Management Program

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

P38-19 Change to Outpatient Therapies Prior Authorization Requirements for Medicare Advantage Subscribers

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

P33-19 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial & Medicare Advantage Lines of Business

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

P35-19 Appeals Policy for no Prior Authorization Effective June 3, 2019

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: : Abr 01, 2019

Bixiye

QP30-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019

Bixiye

QP33-19 SmartChoice Program for Fully Insured Commercial Products

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019

Bixiye

QP32-19 Pharmacy Benefit Exclusion for Glyrx-PF, Libtayo, Lumoxiti, Onpattro, Poteligeo, and Xerava

Wax badan akhri

Taariikhda uu dhaqangalayo Barnaamijka: Mar 27, 2019